We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+12.31%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$33.4B
AUM Growth
+$2.35B
Cap. Flow
-$652M
Cap. Flow %
-1.96%
Top 10 Hldgs %
25.9%
Holding
1,133
New
72
Increased
394
Reduced
425
Closed
76

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$242M
2
AMZN icon
Amazon
AMZN
+$69.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$67M
4
UBS icon
UBS Group
UBS
+$59.2M
5
LW icon
Lamb Weston
LW
+$58.5M

Top Sells

Rank Stock Value
1
AXNX
Axonics, Inc. Common Stock
AXNX
+$105M
2
AAPL icon
Apple
AAPL
+$87.1M
3
APTV icon
Aptiv
APTV
+$80.3M
4
TSCO icon
Tractor Supply
TSCO
+$80M
5
DE icon
Deere & Co
DE
+$78.5M

Sector Composition

Rank Sector Weight
1 Technology 35.56%
2 Healthcare 16.52%
3 Consumer Discretionary 11.68%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTRG icon
526
Essential Utilities
WTRG
$11.8B
$5.22M 0.02%
140,959
+23,006
+20% +$834K
LAUR icon
527
Laureate Education
LAUR
$4.94B
$5.21M 0.02%
357,337
+95,093
+36% +$1.26M
LNTH icon
528
Lantheus
LNTH
$6.58B
$5.19M 0.02%
83,328
+63,728
+325% +$3.75M
PLRX icon
529
Pliant Therapeutics
PLRX
$69.4M
$5.17M 0.02%
347,194
+94
+0% +$1.55K
ASML icon
530
ASML
ASML
$611B
$5.08M 0.02%
5,233
+717
+16% +$636K
IEMG icon
531
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
$5.06M 0.02%
98,000
MLM icon
532
Martin Marietta Materials
MLM
$36B
$5.04M 0.02%
8,210
-1,023
-11% -$558K
VRT icon
533
Vertiv
VRT
$90.3B
$5.02M 0.02%
+61,418
New +$3.86M
MMSI icon
534
Merit Medical Systems
MMSI
$5.15B
$5.01M 0.02%
66,082
+1,995
+3% +$154K
PRU icon
535
Prudential Financial
PRU
$41.2B
$5M 0.02%
42,567
-3,697
-8% -$398K
SANM icon
536
Sanmina
SANM
$10.3B
$4.99M 0.02%
80,300
MKTX icon
537
MarketAxess Holdings
MKTX
$5.75B
$4.96M 0.01%
22,644
-5,791
-20% -$1.37M
CAG icon
538
Conagra Brands
CAG
$7.21B
$4.94M 0.01%
166,548
-157,672
-49% -$4.5M
ITGR icon
539
Integer Holdings
ITGR
$4.29B
$4.9M 0.01%
41,976
SSNC icon
540
SS&C Technologies
SSNC
$19.1B
$4.86M 0.01%
75,432
-6,317
-8% -$392K
KEYS icon
541
Keysight
KEYS
$53.3B
$4.84M 0.01%
30,965
-16,416
-35% -$2.52M
INST
542
DELISTED
Instructure Holdings, Inc.
INST
$4.81M 0.01%
224,752
-58,100
-21% -$1.37M
CBIO
543
Crescent Biopharma
CBIO
$698M
$4.76M 0.01%
15,877
+4
+0% +$1.2K
TEX icon
544
Terex
TEX
$6.67B
$4.76M 0.01%
73,900
-17,900
-19% -$1.05M
APH icon
545
Amphenol
APH
$191B
$4.7M 0.01%
163,072
-598,124
-79% -$15.7M
PAYO icon
546
Payoneer
PAYO
$2.42B
$4.61M 0.01%
948,601
-244,955
-21% -$1.19M
IR icon
547
Ingersoll Rand
IR
$27.9B
$4.6M 0.01%
48,412
-57,471
-54% -$4.92M
VRSN icon
548
VeriSign
VRSN
$26.9B
$4.59M 0.01%
24,213
-18,959
-44% -$3.73M
GNTX icon
549
Gentex
GNTX
$4.72B
$4.58M 0.01%
126,864
HAE icon
550
Haemonetics
HAE
$4.83B
$4.58M 0.01%
53,675
-25
-0% -$1.96K

Similar funds

Axa's Q1 2024 Portfolio in Review

As of Q1 2024, Axa held 1,133 positions worth $33.4B, up 7.6% from $31B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Axa's Q1 2024 filing shows 72 new, 394 increased, 425 reduced and 76 closed positions. Its largest new stake was Lamb Weston: 561,708 shares worth $59.8M. The largest sale was Axonics, Inc. Common Stock, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q1 2024 buy was Lamb Weston: 561,708 shares worth $59.8M.
  • Axa added most to Meta Platforms (Facebook) in Q1 2024, an estimated $242M increase.
  • Axa's biggest Q1 2024 reduction was Axonics, Inc. Common Stock, cutting an estimated $105M.
  • Axa fully exited Archer Daniels Midland in Q1 2024, selling an estimated $53.4M.
  • Axa's ten largest holdings make up 26% of its $33.4B portfolio in Q1 2024.
  • Axa opened 72 new positions and closed 76 in Q1 2024.
  • Axa's portfolio value rose 7.6% quarter-over-quarter to $33.4B.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.